Support and Resistance Levels
Past performance
About Glaxosmithkline Pharmaceuticals Ltd GlaxoSmithKline Pharmaceuticals Limited, a subsidiary of the UK-based GSK Plc., is a prominent player in the Indian pharmaceutical market, with its headquarters in Mumbai. The company operates six branch offices, a manufacturing facility in Nashik, 22 contract manufacturing organizations across India, and a clinical development center in Bangalore. It specializes in manufacturing, distributing, and trading pharmaceuticals, offering a diverse portfolio that includes general medicines, specialty medicines, and vaccines. Their products cover a wide range of therapeutic areas such as anti-infectives, dermatology, oncology, and respiratory diseases, as well as vaccines for conditions like hepatitis, influenza, and cervical cancer.
Founded in 1924, GlaxoSmithKline Pharmaceuticals Limited has a rich history of innovation and expansion in India, marked by strategic mergers and acquisitions. Notable milestones include the acquisition of Novartis' vaccines business and the launch of various innovative products like the Nucala auto-injector and Trelegy Ellipta for COPD treatment. The company has continuously invested in infrastructure, with a significant investment in a new greenfield manufacturing site in Vemgal, Karnataka, designed to achieve zero accidents, defects, and waste.